rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-5-15
|
pubmed:abstractText |
Some studies have previously suggested the involvement of antibodies directed against CD36 (anti-CD36) in the pathogenesis of thrombosis. The aim of this study was to evaluate the prevalence of anti-CD36 in patients with antiphospholipid antibodies (aPL) and its relationship with thrombosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-856X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12747279-Adult,
pubmed-meshheading:12747279-Antigens, CD36,
pubmed-meshheading:12747279-Antiphospholipid Syndrome,
pubmed-meshheading:12747279-Autoantibodies,
pubmed-meshheading:12747279-Female,
pubmed-meshheading:12747279-Humans,
pubmed-meshheading:12747279-Male,
pubmed-meshheading:12747279-Prevalence,
pubmed-meshheading:12747279-Recurrence,
pubmed-meshheading:12747279-Thrombosis
|
pubmed:articleTitle |
Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome.
|
pubmed:affiliation |
Division of Haematology, Favaloro University, Favaloro Foundation, Buenos Aires, Argentina.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|